Clinical Trials Browser

Leukemia × Observation × 90 days × Clear all

NCT03059485 2026-02-04

DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute